| Dr Ansel Philip Amaral, MD, PHD | |
|
455 Pinellas St Ste 400, Clearwater, FL 33756-3356 | |
| (727) 445-1911 | |
| (727) 445-1986 |
| Full Name | Dr Ansel Philip Amaral |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 10 Years |
| Location | 455 Pinellas St Ste 400, Clearwater, Florida |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659790004 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morton Plant Health Services Inc | 2163336777 | 70 |
| Pinellas Ekg Interpreters Inc | 4385608066 | 53 |
| Clearwater Cardiovascular And Interventional Consultants Md Pa | 9436108099 | 21 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Entity Name | Morton Plant Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528049962 PECOS PAC ID: 2163336777 Enrollment ID: O20040115000883 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Entity Name | Pinellas Ekg Interpreters Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013952977 PECOS PAC ID: 4385608066 Enrollment ID: O20041112000584 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Entity Name | Clearwater Cardiovascular & Interventional Consultants Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659396133 PECOS PAC ID: 9436108099 Enrollment ID: O20050120000848 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Entity Name | Cardiovascular Asc Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1619643608 PECOS PAC ID: 6800292178 Enrollment ID: O20210913000515 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ansel Philip Amaral, MD, PHD 455 Pinellas St Ste 400, Clearwater, FL 33756-3356 Ph: (727) 445-1911 | Dr Ansel Philip Amaral, MD, PHD 455 Pinellas St Ste 400, Clearwater, FL 33756-3356 Ph: (727) 445-1911 |
News Archive
Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.
Many young parents are using electronic cigarettes, and despite any evidence for safety, the vast majority of young adults who have used the devices believe they are less harmful than regular cigarettes, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
Dr. David Scott Borislow, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 508 Jeffords St Ste D, Clearwater, FL 33756 Phone: 727-443-7700 Fax: 737-461-4379 | |
Dr. Irma Alves, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-462-7908 Fax: 727-462-7904 | |
Dr. Mark Alan Whiting, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Pinellas St, Suite 350, Clearwater, FL 33756 Phone: 727-462-3696 Fax: 813-635-2637 | |
Dr. Steven Charles Bowman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3251 N Mcmullen Booth Rd, Suite 303, Clearwater, FL 33761 Phone: 727-725-6110 Fax: 727-669-9742 | |
Dr. Mahesh Amin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Pinellas St Ste 330, Clearwater, FL 33756 Phone: 727-724-8611 Fax: 727-724-0425 | |
Dr. Sara Enid Cruz-luna, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1243 S Myrtle Ave, Clearwater, FL 33756 Phone: 727-442-3126 Fax: 727-287-4559 | |
Neisa I Diaz, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 13501 Icot Blvd Ste 114, Clearwater, FL 33760 Phone: 727-754-7880 Fax: 727-754-7885 |